Lixte Biotechnology (LIXT) Competitors $1.52 +0.03 (+2.01%) (As of 11/21/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends LIXT vs. SNGX, AIM, PMCB, SLGL, NLSP, WENA, SNSE, AWH, NKGN, and TLPHShould you be buying Lixte Biotechnology stock or one of its competitors? The main competitors of Lixte Biotechnology include Soligenix (SNGX), AIM ImmunoTech (AIM), PharmaCyte Biotech (PMCB), Sol-Gel Technologies (SLGL), NLS Pharmaceutics (NLSP), ANEW Medical (WENA), Sensei Biotherapeutics (SNSE), Aspira Women's Health (AWH), NKGen Biotech (NKGN), and Talphera (TLPH). These companies are all part of the "pharmaceutical products" industry. Lixte Biotechnology vs. Soligenix AIM ImmunoTech PharmaCyte Biotech Sol-Gel Technologies NLS Pharmaceutics ANEW Medical Sensei Biotherapeutics Aspira Women's Health NKGen Biotech Talphera Lixte Biotechnology (NASDAQ:LIXT) and Soligenix (NASDAQ:SNGX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, community ranking, earnings, media sentiment, analyst recommendations, risk, dividends and valuation. Do institutionals and insiders have more ownership in LIXT or SNGX? 5.1% of Lixte Biotechnology shares are owned by institutional investors. Comparatively, 3.6% of Soligenix shares are owned by institutional investors. 14.8% of Lixte Biotechnology shares are owned by company insiders. Comparatively, 2.8% of Soligenix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is LIXT or SNGX more profitable? Lixte Biotechnology has a net margin of 0.00% compared to Soligenix's net margin of -1,473.38%. Soligenix's return on equity of -223.29% beat Lixte Biotechnology's return on equity.Company Net Margins Return on Equity Return on Assets Lixte BiotechnologyN/A -5,562.77% -130.48% Soligenix -1,473.38%-223.29%-74.18% Which has stronger earnings and valuation, LIXT or SNGX? Lixte Biotechnology has higher earnings, but lower revenue than Soligenix. Lixte Biotechnology is trading at a lower price-to-earnings ratio than Soligenix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLixte BiotechnologyN/AN/A-$5.09M-$1.73-0.88Soligenix$840K10.13-$6.14M-$7.53-0.45 Does the MarketBeat Community favor LIXT or SNGX? Soligenix received 278 more outperform votes than Lixte Biotechnology when rated by MarketBeat users. CompanyUnderperformOutperformLixte BiotechnologyN/AN/ASoligenixOutperform Votes27872.97% Underperform Votes10327.03% Which has more risk & volatility, LIXT or SNGX? Lixte Biotechnology has a beta of -0.17, meaning that its share price is 117% less volatile than the S&P 500. Comparatively, Soligenix has a beta of 1.85, meaning that its share price is 85% more volatile than the S&P 500. Does the media favor LIXT or SNGX? In the previous week, Soligenix had 5 more articles in the media than Lixte Biotechnology. MarketBeat recorded 5 mentions for Soligenix and 0 mentions for Lixte Biotechnology. Soligenix's average media sentiment score of 0.21 beat Lixte Biotechnology's score of 0.00 indicating that Soligenix is being referred to more favorably in the news media. Company Overall Sentiment Lixte Biotechnology Neutral Soligenix Neutral SummarySoligenix beats Lixte Biotechnology on 8 of the 13 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Lixte Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for LIXT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIXT vs. The Competition Export to ExcelMetricLixte BiotechnologyPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.44M$6.49B$5.07B$8.90BDividend YieldN/A8.11%4.99%4.07%P/E Ratio-0.864.8587.8613.46Price / SalesN/A374.821,228.8287.66Price / CashN/A52.5939.5136.27Price / Book-1.5710.216.946.30Net Income-$5.09M$153.61M$119.12M$225.93M7 Day Performance-6.88%-2.00%-1.84%-1.32%1 Month Performance-22.40%-7.47%-3.65%0.60%1 Year Performance-47.90%31.80%31.64%26.23% Lixte Biotechnology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIXTLixte Biotechnology0.0581 of 5 stars$1.52+2.0%N/A-49.7%$3.42MN/A-0.883SNGXSoligenix0.9685 of 5 stars$3.39-3.4%N/A-49.0%$8.51M$840,000.00-0.4520AIMAIM ImmunoTech1.7806 of 5 stars$0.21+5.0%$3.00+1,317.1%-52.0%$13.49M$200,000.00-0.4520News CoverageHigh Trading VolumePMCBPharmaCyte Biotech0.651 of 5 stars$1.75+1.7%N/A-21.1%$13.44MN/A2.732SLGLSol-Gel Technologies3.6414 of 5 stars$0.48+6.7%$5.00+952.4%-68.5%$13.24M$1.55M-1.4050News CoverageGap DownNLSPNLS Pharmaceutics1.2366 of 5 stars$3.37+2.4%N/A+623.1%$12.85MN/A0.006WENAANEW MedicalN/A$0.73-0.5%N/AN/A$12.51MN/A0.00N/AGap UpSNSESensei Biotherapeutics4.8056 of 5 stars$0.48-2.0%$4.33+795.3%-20.0%$12.17MN/A-0.4140News CoverageAWHAspira Women's Health1.6805 of 5 stars$0.75+2.7%$4.40+488.4%-78.5%$12.01M$9.15M-0.62110Analyst ForecastNKGNNKGen BiotechN/A$0.34+6.3%N/A-89.1%$11.94M$80,000.00-0.06N/AGap UpHigh Trading VolumeTLPHTalphera2.1466 of 5 stars$0.70-1.4%$4.50+543.6%N/A$11.91M$650,000.000.0019Gap Up Related Companies and Tools Related Companies SNGX Alternatives AIM Alternatives PMCB Alternatives SLGL Alternatives NLSP Alternatives WENA Alternatives SNSE Alternatives AWH Alternatives NKGN Alternatives TLPH Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LIXT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lixte Biotechnology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lixte Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LIXT Stock Alerts